Therapeutic administration of atomoxetine combined with rTMS and occupational therapy for upper limb hemiparesis after stroke: a case series study of three patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abo M, Kakuda W (2012) Rehabilitation for cerebrovascular disease: current and new methods in Japan. Jpn Med Assoc J 55:240–245
Wieloch T, Nikolich K (2006) Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol 16:258–264
Pekna M, Pekny M, Nilsson M (2012) Modulation of neural plasticity as a basis for stroke rehabilitation. Stroke 43:2819–2828
Tegenthoff M, Cornelius B, Pleger B, Malin JP, Schwenkreis P (2004) Amphetamine enhances training-induced motor cortex plasticity. Acta Neurol Scand 109:330–336
Boyeson MG, Feeney DM (1989) Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol Biochem Behav 35:497–501
Papadopoulos CM, Tsai S, Guillen V, Ortega J, Gwendolyn L, Wolf WA (2009) Motor recovery and axonal plasticity with short-term amphetamine after stroke. Stroke 40:294–302
Martinsson L, Hardemark H, Eksborg S (2007) Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev. doi: 10.1002/14651858.CD002090.pub2
Lokk J, Salman RR, Delbari A (2011) Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke. A randomized, double-blind, placebo controlled trial. Acta Neurol Scand 123:266–273
Schuster C, Maunz G, Lutz K, Kischka U, Sturzenegger R, Ettlin T (2011) Dexamphetamine improves upper extremity outcome during rehabilitation after stroke: a pilot randomized controlled trial. Neurorehabil Neural Repair 25:749–755
Kollins SH, MacDonald EK, Rush CR (2001) Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 68:611–627
Westover AN, Halm EA (2012) Do prescription stimulants increase the risk of adverse cardiovascular events? A systematic review. BMC Cardiovasc Disord 12:41
Gehlert DR, Schober DA, Hemrick-Luecke SK, Krushinski J, Howbert JJ, Robertson DW, Fuller RW, Wong DT (1995) Novel halogenated analogs of atomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain. Neurochem Int 26:47–52
Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699–711
Wernicke JF, Faries D, Girod D, Brown J, Gao H, Kelsey D, Quintana H, Lipetz R, Michelson D, Heiligenstein J (2003) Cardiovascular effects of atomoxetine in children, adolescents and adults. Drug Saf 26:729–740
Upadhyaya HP, Desaiah D, Schuh KJ, Bymaster FP, Kallman MJ, Clarke DO, Durell TM, Trzepacz PT, Calligaro DO, Nisenbaum ES, Emmerson PJ, Schuh LM, Bickel WK, Allen AJ (2013) A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder. Psychopharmacology 226:189–200
Plewnia C, Hoppe J, Hiemke C, Bartels M, Cohen LG, Gerloff C (2002) Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine. Neurosci Lett 330:231–234
Foster DJ, Good DC, Fowlkes A, Sawaki L (2006) Atomoxetine enhances a short-term model of plasticity in humans. Arch Phys Med Rehabil 87:216–221
Gilbert DL, Ridel KR, Sallee FR, Zhang J, Lipps TD, Wassermann EM (2006) Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology 31:442–449
Sczesny-Kaiser M, Bauknecht A, Höffken O, Tegenthoff M, Dinse HR, Jancke D, Funke K, Schwenkreis P (2014) Synergistic effects of noradrenergic modulation with atomoxetine and 10 Hz repetitive transcranial magnetic stimulation on motor learning in healthy humans. BMC Neurosci 15:46
Kakuda W, Abo M, Kobayashi K, Momosaki R, Yokoi A, Fukuda A, Umemori T (2011) Application of combined 6-Hz primed low-frequency rTMS and intensive occupational therapy for upper limb hemiparesis after stroke. NeuroRehabilitation 29:365–371
Kakuda W, Abo M, Shimizu M, Sasanuma J, Okamoto T, Yokoi A, Taguchi K, Mitani S, Harashima H, Urushidani N, Urashima M, Investigators NEURO (2012) A multi-center study on low-frequency rTMS combined with intensive occupational therapy for upper limb hemiparesis in post-stroke patients. J Neuroeng Rehabil 9:4
Abo M, Kakuda W, Momosaki R, Harashima H, Kojima M, Watanabe S, Sato T, Yokoi A, Umemori T, Sasanuma J (2014) Randomized, multicenter, comparative study of NEURO versus CIMT in poststroke patients with upper limb hemiparesis: the NEURO-VERIFY study. Int J Stroke 9:607–612
Wassermann EM (1998) Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996. Electroencephalogr Clin Neurophysiol 108:1–16
Gladstone DJ, Danells CJ, Black SE (2002) The Fugl-Meyer assessment of motor recovery after stroke: a critical review of its measurement properties. Neurorehabil Neural Repair 16:232–240
Wolf SL, Catlin PA, Ellis M, Archer AL, Morgan B, Piacentino A (2001) Assessing wolf motor function test as outcome measure for research in patients after stroke. Stroke 32:1635–1639
Pandyan AD, Johnson GR, Price CI, Curless RH, Barnes MP, Rodgers H (1999) A review of the properties and limitations of the Ashworth and modified Ashworth scales as measures of spasticity. Clin Rehabil 13:373–383
Corti M, Patten C, Triggs W (2012) Repetitive transcranial magnetic stimulation of motor cortex after stroke: a focused review. Am J Phys Med Rehabil 91:254–270
Yamada N, Kakuda W, Senoo A, Kondo T, Mitani S, Shimizu M, Abo M (2013) Functional cortical reorganization after low-frequency repetitive transcranial magnetic stimulation plus intensive occupational therapy for upper limb hemiparesis: evaluation by functional magnetic resonance imaging in poststroke patients. Int J Stroke 8:422–429